Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- Case-Based Roundtable
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
- Buy-and-Bill
Article
Innovation comes to wound products and therapies
The competition among dermal substitute manufacturers to meet the needsof a burgeoning population of chronic wound sufferers has resulted in agrowth market of continually improving products, according to Eliot N. Mostow,M.D., an Akron, Ohio, dermatologist and wound care specialist. The escalationof diabetes and diabetes-related wounds, along with an aging population,are just two factors influencing this trend, he said.
Related Videos
Related Content
